| ★ |  Whitepaper: Procedural and regulatory know how for China biotech in the EU | | 23 | Irlanda | |
| 14 |  Health Policy Conference | | 1.4K | Bélgica | 85 |
| 17 |  Apply AI sectoral webinar – healthcare & pharma | | 1.0K | — | 84 |
| 8 |  Understanding the Pharmaceutical Industry (10 Minutes) | BioTech Whisperer @biotechwhisperer | 590 | Estados Unidos | 85 |
| 7 |  Securing Europe’s future through the EU Stockpiling Strategy - Tackling health challenges | | 283 | Bélgica | 85 |
| 10 |  GDF2026 - ICH M13A High-Risk vs. Low-Risk Case Studies – Bioequivalence (BE) Implications | U.S. Food and Drug Administration @us_fda | 251 | Estados Unidos | 85 |
| 18 |  Whitepaper: Survey results: How to engage healthcare decision-makers | | 114 | Irlanda | 84 |
| 16 |  #KRA & #KPI of Inhouse Expert (English): NABET Compliance | EIA PRACTITIONER @ak1motivator | 60 | India | 84 |
| 1 |  Regulatory Affairs overview | | 57 | Irlanda | 89 |
| 12 |  Whitepaper: COVID-19 vaccines: Post-authorisation safety surveillance | | 48 | Irlanda | 85 |
| 20 |  #KRA & #KPI of #In-House #Expert: #NABET #Compliance (#Hindi) #QMS | EIA PRACTITIONER @ak1motivator | 44 | India | 84 |
| 4 |  Whitepaper: ICON ICH GCP implementation | | 41 | Irlanda | 87 |
| 5 |  Whitepaper: Making sense of the rapidly changing biosimilars landscape | | 38 | Irlanda | 87 |
| 6 |  Whitepaper: The future of oncology biosimilars: Considerations for development through 2040 | | 22 | Irlanda | 87 |
| 2 |  Whitepaper: Accelerating access: Expedited and harmonised pathways for innovative therapies | | 19 | Irlanda | 89 |
| 15 |  Presentación del estudio sobre la regulación del sector farmacéutico en América Central | Unión Europea en Centroamérica @ueencentroamerica | 17 | Costa Rica | 84 |
| 19 |  Claves para la Industria Farmacéutica y Biotecnológica en América Latina (Segunda parte) | | 11 | Ecuador | 84 |
| 3 |  Regulatory Landscapes Across the World - FDA and EMA Guidelines (11 Minutes) | Microlearning Daily @microlearningdaily | 10 | Singapur | 88 |
| 11 |  BIOLATAM Digital 2025: 'Convergencia regulatoria en Iberoamérica: Estrategias fast-track COFEPRIS' | AseBio - Asociación Española de Bioempresas @asebio-asociacion | 9 | España | 85 |
| 9 |  Why Is Biotech Regulation So Complex? | Everyday Bioethics Expert @everydaybioethicsexpert | 3 | Estados Unidos | 85 |